Avellino Labs
Dr. Thompson is a board-certified ophthalmologist and professor of ophthalmology at the Sanford USD School of Medicine. Dr. Thompson earned his Doctorate of Medicine at the University of South Dakota’s School of Medicine and completed his residency at the University of Missouri/Columbia. With more than 25 years of experience, Dr. Thompson has performed more than 75,000 vision correction surgeries worldwide and remains among a select group of refractive and cataract surgeons who prioritize the use of innovative, advanced surgical techniques. As a leading international researcher, Dr. Thompson has played an important role in the discovery and development of the advanced technologies and techniques used in both laser and implant vision correction surgeries. Serving as the medical monitor lead, or principal investigator, Dr. Thompson has led over 65 FDA-monitored clinical trials and has published numerous papers and book chapters on his findings. He is a fellow of the American College of Surgeons, and practices in Sioux Falls, SD.
This person is not in the org chart
This person is not in any offices
Avellino Labs
Avellino Labs is a global leader in gene therapy and molecular diagnostics, and the pioneer in personalized medicine for eye care. Avellino Labs is pioneering CRISPR gene editing to manage and potentially cure inherited diseases. Avellino Labs continues to expand its diagnostics capabilities, building on the success of the world's first DNA test to confirm the presence of genetic indicators that are positively associated with corneal dystrophies, providing life-changing information for patient treatment decisions and follow up care. Avellino Labs is headquartered in Silicon Valley, California, with operations in Korea, Japan, China and the UK.